CM.APS.P203. The Forest vs. the Trees: Caring for Populations of Patients with Diabetes
Zone 3
SU3026 / 3026 - Access To Specialty Cardiovascular Care And Uptake Of Cardioprotective Anti-hyperglycemic Agents Among Adults With Type 2 Diabetes: A Cohort Study
Arash Aghajani Nargesi, New Haven, CT; Callahan Clark, Minneapolis, MN; Mengni Liu, Minneapolis, MN, Elmhurst, NY; Abraham Reddy, Minneapolis, MN, Elmhurst, NY, Minneapolis, MN; Sam Amodeo, Minneapolis, MN, Elmhurst, NY, Minneapolis, MN, Minneapolis, MN; Rohan Khera, Yale Sch of Med, New Haven, CT
HF.APS.P123. Novel Diagnostic Methods and Predictors for Cardiovascular Disease
Zone 2
SU2139 / 2139 - Prompting Providers With Electronic Alerts Improves Long-term Uptake Of Guideline-directed Medical Therapy For Heart Failure
Lama Ghazi, Yu Yamamoto, Yale Univ, New Haven, CT; Ralph J Riello III, Yale Sch of Med, New Haven, CT; Melissa Martin, Yale Sch of Med, New Haven, CT, New Haven, CT; Kyle O'Connor, Yale Sch of Med, New Haven, CT, New Haven, CT, New Haven, CT; Joanna Huang, Yale Sch of Med, New Haven, CT, New Haven, CT, New Haven, CT, Princeton, NJ; Tope Olufade, AstraZeneca, Wilmington, DE; Jim McDermott, Astra Zeneca, Wilmington, DE; Kristine Anne Sobolewski, Karthik Linganathan, AstraZeneca, MA; Michael Fuery, New Haven, CT; Silvio E Inzucchi, YALE UNIVERSITY SCHOOL OF MED, Stratford, CT; F. Perry Wilson, YALE UNIVERSITY SCHOOL OF MED, Stratford, CT, New Haven, CT; Nihar R Desai, Yale Sch of Med, New Haven, CT; Tariq Ahmad, Yale Medical Ctr, Guilford, CT
HF.APS.P124. Drugs, Drugs and More Drugs in Heart Failure: Impact on Outcomes
Zone 2
SU2151 / 2151 - Defining Phenotypic Representativeness Of The TOPCAT Trial To A Real-world Electronic Health Record Using Multidimensional Phenomaps
Phyllis Thangaraj, Yale Univ, New Haven, CT; Evangelos Oikonomou, New Haven, CT; Rahul Jayaram, Yale Univ, New Haven, CT; Arash Aghajani Nargesi, Yale Univ, New Haven, CT, New Haven, CT; Marc Suchard, Yale Univ, New Haven, CT, New Haven, CT, Los Angeles, CA; Rohan Khera, Yale Sch of Med, New Haven, CT
CH.APS.P175. Single Ventricle - Pediatric Cardiology 2
Zone 4
SU4013 / 4013 - Clinical Characteristics And Predictors Of The “Good Fontan”: A Multi-institutional Study
Robert W. Elder, Yale Sch of Med, New Haven, CT; Anne M Valente, BOSTON CHILDRENS HOSPITAL, Boston, MA; Brooke Davey, Connecticut Children's, Hartford, CT; Fred Wu, Boston Children s Hosp, Boston, MA; Nancy A Drucker, Univ of Vermont Medical Cente, Burlington, VT; Kristin Lombardi, Warren Alpert Medical Sch at Brown Univ, Providence, RI; Seohyuk Lee, Yale Sch of Med, New Haven, CT; Nicole St. Clair, Boston Children's Hosp, Boston, MA; Olga H Toro-salazar, CONNECTICUT CHILDRENS MEDICAL CTR, Hartford, CT; Rahul Rathod, BOSTON CHILDRENS HOSPITAL, Boston, MA
DD.APS.P121. Drug Discovery for Cardiovascular Disease
Zone 1
SU1073 / 1073 - Renalase Peptide Agonist Therapy Normalizes The Cardiac Response To Pressure Overload In Chronic Kidney Disease
Govind Krishna Kumar Nair, Jiasheng Zhang, Xiaojia Guo, nicole guerrera, Xiaohong Wu, Xiaoyue Hu, Fred S. Gorelick, Robert Safirstein, Frank J Giordano, Lawrence H Young, Gary V. Desir, Yale Univ Sch of Med, New Haven, CT
EP.APS.P204. Epidemiology of Peripheral Artery Disease
Zone 3
SU3072 / 3072 - The Association Between Neighborhood Distress And Outcomes Following Peripheral Vascular Intervention
Eric Strand, Kim G Smolderen, Gaelle Romain, Yale Univ, New Haven, CT; Matthew Burg, Yale Sch of Med, West Haven, CT; Kamil Faridi, Yale Sch of Med, New Haven, CT; Keith B Churchwell, YALE NEW HAVEN HOSPITAL, New Haven, CT; Carlos Mena-Hurtado, Yale Univ, New Haven, CT
SU3073 / 3073 - In-Hospital Outcomes In Patients With Peripheral Artery Disease Hospitalized For Acute Myocardial Infarction: From The NCDR Chest Pain Mi Registry
Kamil F Faridi, Yale Sch of Med, New Haven, CT; Shuang Li, Tracy Y Wang, DCRI, Durham, NC; Carlos Mena-Hurtado, Kim G Smolderen, Yale Univ, New Haven, CT; Jennifer A Rymer, Duke, Durham, NC; Jeptha P Curtis, YALE UNIVERSITY, New Haven, CT; Eric A Secemsky, BIDMC, Boston, MA
EP.APS.P206. Rigor and Reason in Understanding Patterns of Cardiovascular Risk
Zone 3
SU3076 / 3076 - An Adaptive Strategy Of Predictive Enrichment To Increase Efficiency Of Randomized Clinical Trials Using Machine Learning: A Simulation Of The IRIS Trial
Evangelos K Oikonomou, Yale Sch of Med, New Haven, CT; Marc A Suchard, Los Angeles, CA; Walter N Kernan Jr., YALE UNIVERSITY, New Haven, CT; Lawrence H Young, YALE UNIV SCH MED, New Haven, CT; Silvio E Inzucchi, YALE UNIVERSITY SCHOOL OF MED, Stratford, CT; Rohan Khera, Yale Sch of Med, New Haven, CT
SU3088 / 3088 - Do Beta-blockers Confer Cardiovascular Protection In Patients With Stable Coronary Artery Disease In The Contemporary Era?
Lucas C Godoy, Univ of Toronto, Toronto, ON, Canada; Michael E Farkouh, Peter Munk Cardiac Ctr, Toronto, ON, Canada; Peter Austin, ICES, Toronto, ON, Canada; Baiju Shah, Sunnybrook Health Sciences Ctr, Toronto, ON, Canada; Feng Qiu, ICES, Toronto, ON, Canada; Cynthia Jackevicius, Western Univ, Pomona, CA; Harindra C Wijeysundera, Sunnybrook Health Sciences Ctr, Toronto, ON, Canada; Harlan M Krumholz, Yale Univ, New Haven, CT; Dennis T Ko, Sunnybrook Health Sciences Ctr, Toronto, ON, Canada
QU.APS.P188. Learning Health Systems: the Supporting Science
Zone 3
SU3172 / 3172 - Use Of Electronic Health Records To Develop An Actionable Taxonomy Of Patients With Persistent Hypertension
Yuan Lu, Cindy Hu, Hazar Khidir, Yale Univ, New Haven, CT; Cesar Caraballo, Yale Sch of Med, New Haven, CT; Shiwani Mahajan, Yale Univ Sch of Med, New Haven, CT; Erica S Spatz, YALE UNIVERSITY SCHOOL MEDICINE, New Haven, CT; Leslie Curry, YALE, Killingworth, CT; Harlan M Krumholz, Yale Univ, New Haven, CT
VA.APS.P178. Vascular Medicine From Head to Toe: Looking to a Bright Research Horizon 2
Zone 4
SU4234 / 4234 - The Impact Of Ejection Fraction On Major Adverse Limb Events After Lower Extremity Revascularization
Yasser Jamil, Yale Sch Of Med, New Haven, CT; Joshua Huttler, Yale Univ Sch Of Med, CT; Dana Alameddine, Haoran Zhuo, Yale Univ Sch Of Med, New Haven, CT; Carlos Mena-Hurtado, Yale Univ, New Haven, CT; Eric Jose Velazquez, Yale Univ Sch of Med, New Haven, CT; Raul J Guzman, Yale New Haven Hosp, New Haven, CT; Cassius Iyad I Ochoa Chaar, Yale Sch of Med, New Haven, CT
IN.APS.P325 - TAVR in Special Populations
Zone 2
SU2365 / 2365 - Impact of Dementia on Inpatient Outcomes and Readmission Risks After Transcatheter Aortic Valve Replacement
Dae Yong Park, Cook County Health, Chicago, IL; Muhammad Khawar Sana, Chicago, IL; Sami Shoura, Hasan Hammo, Cook County Health, Chicago, IL; Jiun-Ruey Hu, New Haven, CT; Angela Lowenstern, Vanderbilt Univ, Nashville, TN; Yousif Ahmad, Vanderbilt Univ, Nashville, TN, New Haven, CT; Michael Nanna, Vanderbilt Univ, Nashville, TN, New Haven, CT, New Haven, CT
QU.MDP32 - Improving Cardiovascular Health: Prediction, Processes and Programs
MP112 - Development of a 30-Day Health Status Prediction Model for High-Risk Transfemoral Carotid Artery Stenting Using a Simple Machine Learning Algorithm
Kristie M Harris, Gaelle Romain, Jacob Cleman, Carlos Mena-Hurtado, Kim G Smolderen, Yale Sch of Med, New Haven, CT
November 7
NE.AOS.428. Inflammation and Cardiovascular Complications in Patients With Kidney Disease
S101B
390 - Prevalence And Characteristics Of Systemic Inflammation In Adults With Atherosclerotic Cardiovascular Disease And Chronic Kidney Disease: Results From The National Health And Nutrition Examination Survey
Michael Nanna, Yale Univ, New Haven, CT; Lance Sloan, Texas Inst for Kidney and Endocrine Disorders, Lufkin, TX; Mads Faurby, Lise Lotte N Husemoen, Gamze Tombak, Novo Nordisk A/S, Søborg, Denmark; Deepak Yerragolam, Novo Nordisk Service Ctr Pvt Ltd, Bangalore, India; Naveed Sattar, Univ of Glasgow, Glasgow, United Kingdom
MP.AOS.472. Inflammatory Mechanisms of Cardiac Disease
S102A
405 - AT1R Autoantibody Levels Are Elevated In Patients Who Required Immunosuppression Escalation In Immune Checkpoint Inhibitor Mediated Myocarditis
Narjes Akhlaghi, Yale, New Haven, CT; Miles Shen, New Haven, CT; Laurine Bow, Maureen Miller, Yale, New Haven, CT; John Hwa, YALE SCHOOL MEDICINE, New Haven, CT; Stephanie Halene, Yale, New Haven, CT; Lauren A Baldassarre, Yale Univ, New Haven, CT; Jennifer M Kwan, Yale, New Haven, CT
VA.AOS.477. Peripheral Artery Disease - A Matter of Life and Limb
S106B
419 - A Call To Action For Mental Health Needs Amongst Patients Diagnosed With Critical Limb Ischemia: Insights From The Scope-cli Registry
Kim G Smolderen, Yale Univ, New Haven, CT; Mehdi H Shishehbor, Univ Hosp of Cleveland, Cleveland, OH; Olamide Alabi, Emory Univ, Atlanta, GA; Robert Fitridge, The Univ of Adelaide, Adelaide, Australia; Jeremy A Provance, Yale Sch of Med, New Haven, CT; Trissa Babrowski, UNIVERSITY OF CHICAGO, Chicago, IL; Gaelle Romain, Yale Univ, New Haven, CT; PETER A SOUKAS, MIRIAM CARDIOLOGY, PROVIDENCE, RI; Matthew C Bunte, MIRIAM CARDIOLOGY, PROVIDENCE, RI, Leawood, KS; Lindsey Scierka, Yale Univ, New Haven, CT; Evy van Roij, Yale Univ, New Haven, CT, New Haven, CT; Carlos Mena-Hurtado, Yale Univ, New Haven, CT; On Behalf of the SCOPE-CLI Consortium
EA.RFO34. New insights into Atrial Fibrillation Ablation
Zone 4
577 - Regional Variation In Atrial Fibrillation Ablation Care For Medicare Beneficiaries Across The United States
Jonathan Hanna, Yale Sch of Med, New Haven, CT; James V Freeman, YALE UNIV SCHOOL MEDICINE, New Haven, CT; James Hummel, Yale Sch of Med, New Haven, CT; Jeptha P Curtis, YALE UNIVERSITY, New Haven, CT; Zhenqiu Lin, YALE UNIVERSITY, New Haven, CT, Cheshire, CT; Joseph Akar, Yale Univ, New Haven, CT; Rohan Khera, Yale Sch of Med, New Haven, CT
580 - Characteristics And In-hospital Outcomes Of Patients Undergoing Pulmonary Vein Isolation With And Without Adjunctive Lesions: Insights From The Ncdr Afib Ablation Registry
Douglas J Darden, La Jolla, CA; Omar M Aldaas, Corona, CA; Chengan Du, Yale Univ, New Haven, CT; Gregory K Feld, Univ of California San Diego, La Jolla, CA; Krishna Pothineni, Univ of California San Diego, La Jolla, CA, KS; Rakesh Gopinathannair, Dhanunjaya R Lakkireddy, Kansas City Heart Rhythm Inst, Overland Park, KS; Jeptha P Curtis, YALE UNIVERSITY, New Haven, CT; James V Freeman, YALE UNIV SCHOOL MEDICINE, New Haven, CT; Joseph Akar, Yale Univ, New Haven, CT; Jonathan C Hsu, UNIVERSITY OF CALIFORNIA SAN DIEGO, La Jolla, CA
EP.APS.P290. Next Steps in Hypertension Management
Zone 3
MO3008 / 3008 - Mobile Health Interventions And Remote Blood Pressure Monitoring In Underserved Populations: A Systematic Review And Meta-analysis
Miriam Katz, New York Medical Coll, NY; Reed Mszar, Georgetown Univ, DC; Alyssa A Grimshaw, Yale Univ, West Haven, CT; Erica S Spatz, YALE UNIVERSITY SCHOOL MEDICINE, New Haven, CT
HF.APS.P314. My Achy Breaky Heart: Takotsubos, Hypertropic Cardiomyopathy and Valvular Disease
Zone 2
MO2131 / 2131 - Incidence And Risk Factors For Takutsubo Syndrome After Inpatient Chemotherapy : Nationwide Readmissions Database Analysis
Jay Parekh, Sun-Joo A Jang, Aslihan Yerlikaya, Yale New Haven Health, Bridgeport, CT; Eejung Kim, Yale New Haven Hosp, New Haven, CT; Jong Chul Park, Harvard Medical Sch, Boston, MA; Illhwan Yeo, Weill Cornell Medical Coll, NY; Avirup Guha, Medical Coll of Georgia, Augusta, GA; Tariq Ahmad, Yale Medical Ctr, Guilford, CT
IM.APS.P245. The Nuclear Cardiology 3I's: Ischemia, Inflammation and Infiltrative disease
Zone 2
MO2186 / 2186 - Obstructive Sleep Apnea Severity And Abnormal Right Ventricular Flow Reserve In Adult Osa Patients Who Received Rubidium-82 Cardiac Pet Perfusion Imaging.
Ehimen C Aneni, Yale Univ, New Haven, CT; Edward J Miller, YALE UNIVERSITY SCHOOL OF MEDICINE, New Haven, CT; Gul Jana Saeed, YALE UNIVERSITY SCHOOL OF MEDICINE, New Haven, CT, Karachi, Pakistan; Robert deKemp II, uOttawa Heart Inst, Ottawa, ON, Canada; RAN KLEIN, Univ of Ottawa, Ottawa, ON, Canada; Rob S Beanlands, UNIVERSITY OTTAWA HEART INSTITUTE, Ottawa, ON, Canada; Henry KLAR Yaggi IV, Yale Univeristy Sch of Med, New Haven, CT; Albert J Sinusas, YALE UNIVERSITY SCHOOL MEDICINE, New Haven, CT; Stephanie Thorn, YALE UNIVERSITY, New Haven, CT
PD.APS.P235. Advances in Curricular and Educational Programs in Cardiology
Zone 2
MO2295 / 2295 - Shared Curriculum Delivery Gaps Among Advanced Heart Failure And Transplant Cardiology Fellowship Programs
Michael H Beasley, Donna Windish, Yale Sch of Med, New Haven, CT
DD.MDP42. Pharmacological Research in Cardiac Electrophysiology
Moderated Posters 2, Science and Technology Hall
MP229 - Optical Mapping In Atrial Engineered Heart Tissues Reveals Proarrhythmic Potential Of The Anti-AF Agent Vernakalant
Ilhan Gokhan, Afia Sarpong Frimpong, Marine Cacheux, Stuart G Campbell, Yale Univ, New Haven, CT; Fadi G Akar, YALE UNIVERSITY, New Haven, CT
EA.APS.P278. Broadening Our Understanding of Anticoagulation in the Setting of Atrial Fibrillation
Zone 4
MO4086 / 4086 - Association Between Oral Anticoagulant Type And Hospital Readmission Rates Following Myocardial Infarction With Percutaneous Coronary Intervention In Patients With Nonvalvular Atrial Fibrillation
Nihar Desai, Yale Sch of Med, New Haven, CT; Afraim Botros, Bristol Myers Squibb, Lawrenceville, NJ; Ankita Panda, Mu Sigma, Northbrook, IL; Qian Xia, Bristol Myers Squibb, Princeton Pike, NJ; Keith Huff, Bristol Myers Squibb, Lawrenceville, NJ
GR.APS.P300. Race, Ethnicity and Cardiovascular Health
Zone 3
MO3041 / 3041 - Trends In Prevalence And Treatment Of Metabolic Syndrome And Individual Components By Race/ethnicity, 1999-2020
Yuan Lu, Xumin Li, Yale Univ, New Haven, CT; Yuntian Liu, New Haven, CT; Cesar Caraballo, Yale Sch of Med, New Haven, CT; Shiwani Mahajan, Yale Univ Sch of Med, New Haven, CT; Daisy Massey, Yale Univ Sch of Med, New Haven, CT, New Haven, CT; Erica S Spatz, YALE UNIVERSITY SCHOOL MEDICINE, New Haven, CT; Jeph Herrin, FBA, Charlottesville, VA; Harlan M Krumholz, Yale Univ, New Haven, CT
IN.APS.P242. The Latest and the Greatest Research on Left Atrial Appendage Procedures
Zone 2
MO2279 / 2279 - Safety And Effectiveness Of Pre-procedure Imaging For Percutaneous Left Atrial Appendage Occlusion: Insights From The National Cardiovascular Data Registry (NCDR) LAAO Registry
John-Ross D Clarke, Beth Israel Deaconess Medical Ctr, Boston, MA; Angela Y Higgins, Maine Health, Scarborough, ME; Yongfei Wang, YALE UNIVERSITY SCHOOL OF MEDICINE, Cheshire, CT; Kamil Faridi, Yale Sch of Med, New Haven, CT; Jeptha P Curtis, YALE UNIVERSITY, New Haven, CT; James V Freeman, YALE UNIV SCHOOL MEDICINE, New Haven, CT; Daniel Friedman, Duke Univ, Durham, NC
VA.APS.P276. Every Step Counts: Insights from the Latest Research in PAD
Zone 4
MO4228 / 4228 - Development And Validation Of The Peripheral Artery Questionnaire For Critical Limb Ischemia-(paq-cli) Instrument
Kim G Smolderen, Yale Univ, New Haven, CT; John Spertus, Saint Luke's Mid America Heart Inst, Kansas City, MO; Gaelle Romain, Yale Univ, New Haven, CT; Christina Pacheco, Kansas Univ, Kansas City, KS; Kate Scott, Saint Luke's Mid America Heart Inst, MO; Nancy Stone, Saint Luke's Mid America Heart Inst, MO, Kansas City, MO; Lindsey Scierka, Yale Univ, Cheshire, CT; Christine Fuss, Mid America Heart Inst, Kansas City, MO; Evy van Roij, Carlos Mena-Hurtado, Yale Univ, New Haven, CT
HT.AOS.434. Wearable Devices to Improve Cardiovascular Disease Outcomes
S104B
440 - Use Of Wearable Devices By Patients With And At-risk For Cardiovascular Disease In The United States: A Nationally Representative Study
Lovedeep S Dhingra, Yale Sch of Med, New Haven, CT; Arya Aminorroaya, CORE, Yale Sch of Med, New Haven, CT; Evangelos Oikonomou, CORE, Yale Sch of Med, New Haven, CT, New Haven, CT; Arash Aghajani Nargesi, CORE, Yale Sch of Med, New Haven, CT, New Haven, CT, New Haven, CT; Rohan Khera, Yale Sch of Med, New Haven, CT
GE.APS.P216. Genes and Environment in 2022
MO1034 / 1034 - Intriguing Genetic Overlap Between SCAD and TAD
Syeda Manahil Haider Jeoffrey Jeoffrey, Asanish Kalyanasundaram, Mohammad Zafar, Bulat A Ziganshin, John A Elefteriades, YALE UNIVERSITY SCHOOL MEDICINE, New Haven, CT